April 17, 2018 / 2:05 PM / 4 months ago

BRIEF-ICON Announces Deal With Intel Allowing Integration Of The Intel Pharma Analytics Platform For Clinical Trials

April 17 (Reuters) - ICON PLC:

* ICON ANNOUNCES AGREEMENT WITH INTEL ALLOWING INTEGRATION OF THE INTEL® PHARMA ANALYTICS PLATFORM FOR CLINICAL TRIALS

* ICON PLC - AGREED ON PRELIMINARY DEAL TERMS WITH INTEL TO ENABLE ICON TO OFFER INTEL PHARMA ANALYTICS PLATFORM FOR USE IN CLINICAL TRIALS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below